Daisies offer a double boost for prostate cancer treatment

March 8, 2018, Freshscience
Katherine Morel and supervisor Professor Pam Sykes are using a compound from daisies to improve prostate cancer treatments. Credit: Flinders University

A compound derived from feverfew daisies can boost radiotherapy for the treatment of prostate cancer. The compound reduces the therapy's side effects and increases its cancer-killing ability.

Although to treat prostate can be highly effective, damage to nearby healthy tissues is common. This damage results in debilitating side effects, such as impotence and incontinence.

Research by Katherine Morel from the Flinders Centre for Innovation in Cancer at Flinders University has shown that parthenolide, an anti-inflammatory compound originally identified in feverfew daisies, can stimulate healthy tissues to protect themselves from damage during radiotherapy.

"In mice treated with the compound before radiation therapy, radiation-induced in their healthy tissues dropped by more than 70 percent," she says.

As an added bonus, the compound simultaneously doubled the ability of the radiotherapy to kill the prostate tumours in mice, by making the cancer cells more susceptible to the treatment.

"These results are exciting and lay the groundwork for future clinical trials," says Katherine.

"We hope that this compound could both improve survival rates for prostate cancer, as well as protect patients from the unwanted side effects of the treatment."

Feverfew daisies have long been used as a herbal treatment for migraines and other conditions due to the presence of like parthenolide in the plant. However this treatment uses a highly concentrated form of the compound, the equivalent Katherine says to eating a truckload of the daisies.

While the research is focussed on for now, Katherine says a similar approach could work when using radiotherapy to treat other types of cancer.

Explore further: Viral gene therapy could improve results from breast reconstruction after cancer treatment

Related Stories

Viral gene therapy could improve results from breast reconstruction after cancer treatment

January 24, 2018
A new type of gene therapy delivered using a virus could protect healthy tissues from the harmful side-effects of radiotherapy after cancer treatment, a new study reports.

PSMA PET/CT visualizes prostate cancer recurrence early, impacts radiation therapy

February 1, 2018
A nuclear medicine scan may locate prostate cancer recurrence after radical prostatectomy early after disease recurrence and could help guide salvage radiotherapy, according to new research from the University of California ...

Big data analysis predicts risk of radiotherapy side effects

November 7, 2017
Analysing big data to predict men's risk of side effects could help personalise radiotherapy treatment for prostate cancer, according to new research presented at the National Cancer Research Institute's (NCRI) Cancer Conference ...

Pelvis-targeting radiotherapy safe for prostate cancer patients

September 27, 2017
A form of radiotherapy targeting the pelvis is safe for men with advanced localised prostate cancer, according to a new study.

Discovery suggests better way to treat certain prostate cancers, lymphomas

November 10, 2017
Certain prostate cancers and lymphomas have a major genetic weakness that doctors can exploit to help save patients' lives, researchers at the University of Virginia School of Medicine have discovered.

Blood pressure tablets offer radiotherapy protection for prostate cancer patients

October 22, 2015
Blood pressure medication could help protect men from complications arising from radiotherapy for prostate cancer, a new study by researchers at the University of Dundee has found.

Recommended for you

Metastatic lymph nodes can be the source of distant metastases in mouse models of cancer

March 22, 2018
A study by Massachusetts General Hospital (MGH) investigators finds that, in mouse models, cancer cells from metastatic lymph nodes can escape into the circulation by invading nodal blood vessels, leading to the development ...

Could a pap test spot more than just cervical cancer?

March 22, 2018
Pap tests have helped drive down rates of cervical cancer, and a new study suggests they also could be used to detect other gynecologic cancers early.

Gene-based test for urine detects, monitors bladder cancer

March 22, 2018
Researchers at The Johns Hopkins Kimmel Cancer Center have developed a test for urine, gathered during a routine procedure, to detect DNA mutations identified with urothelial cancers.

Researchers identify compound to prevent breast cancer cells from activating in brain

March 22, 2018
Researchers at Houston Methodist used computer modeling to find an existing investigational drug compound for leukemia patients to treat triple negative breast cancer once it spreads to the brain.

Researchers examine role of fluid flow in ovarian cancer progression

March 22, 2018
New research from Virginia Tech is moving physicians closer to pinpointing a predictor of ovarian cancer, which could lead to earlier diagnosis of what is know as the "silent killer."

Probing RNA epigenetics and chromatin structures to predict drug resistance in leukemia

March 22, 2018
Drug resistance is a major obstacle to effective treatment for patients with cancer and leukemia. Epigenetic modifying drugs have been proven effective for some patients with hematologic malignancies, such as myelodysplastic ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.